AdvertisementAdvertise with NZME.
Latest fromFisher and Paykel Healthcare
Trump trade wars: What impact tariffs will have on Kiwi businesses
New Zealand will feel the indirect impact of America's policy on world trade, experts say.
Top NZ company says Trump’s US tariffs will increase costs, share price falls
Fisher & Paykel Healthcare makes a lot of products in Mexico, now a target of tariffs.
Market close: NZ stocks end day lower
The local market was directionless as it snapped its positive start to the week.
Stock Takes: US stocks rally on Trump win while the rest the world waits
Sharemarket investors are waiting to see how a new US trade policy will play out.
The company that had its share price jump 900% in a year
How one company achieved the best performance – then lost all its gains.
F&P Healthcare shares climb as revenue jumps 10 per cent
F&P Healthcare rallies after reporting strong annual revenue growth.
Stock Takes: Results season to reveal extent of NZ’s downturn
Company results, due this month, are expected to show how stressed the economy is.
Market close: NZ stocks on firm note, reporting season disappoints
The NZ market eked out a slight gain despite a surge among international markets.
Market close: Shares dip as interest rate cut question weighs on investors
Transport stocks were also under pressure after Maersk said it’s avoiding the Red Sea.
Market close: NZ sharemarket ends roller coaster year
The 'damp end' to the year is not just outside, but in the sharemarket too.
Opinion: Stop losing your marbles over weight-loss wonder drugs
OPINION: Weight-loss drug headlines mask an attractive longer-term picture.
Fisher & Paykel Healthcare ups dividend
Predicted full-year result better than many analysts had been expecting.
Market close: NZ stocks drift as company results fail to inspire
It was another topsy-turvy day for the NZ sharemarket.
Crucial talks imminent in Fisher & Paykel Healthcare industrial action
The chances of averting a strike at a major factory hinge on Wednesday's talks.
Fisher & Paykel Healthcare staff upset at overtime impasse
More than 1500 staff at giant Kiwi firm in dispute over pay, overtime.
Stock Takes: What’s eating Fisher & Paykel Healthcare?
Since June 30, Fisher & Paykel Healthcare's stock has fallen by 14 per cent.
Stock Takes: Synlait’s big reveal, Fisher and Paykel's investor day
More light will be shed on the state of play with cash-strapped Synlait Milk on Monday.
Fisher & Paykel’s 30-year master plan requires 'discipline'
The medical device company is on a crusade against 'short-termism'.
Market close: Tourism Holdings leads way after profit turnaround
The New Zealand sharemarket finished the day higher after a late surge.
NZ Inc makes big push in India with business delegation
New Zealand will send one of its largest business delegations to India next week.
Jarden Brief: Meta on a Quest for new VR subscription service
VR attempt to curb the recent trajectory of multi-billion operating loss.
Post-Covid reality check? F&P Healthcare profit drops 34pc
F&P Healthcare's earnings have fallen to more normal levels after a big Covid-surge.
Who’s in the running to handle possible Auckland Airport share sale?
Meanwhile, details emerge of Virgin Australia's re-listing plans.
Markets with Madison: Analysts eyeing Fisher & Paykel hit, upside for aged care
FPH is extraordinarily overvalued, Forsyth Barr says.
Jarden Brief: Chip war heats up as US-China competition sparks strict new rules
Restrictions part of US effort to impede Beijing’s ambitions while ensuring stable supply.
F&P Healthcare shares soar on revenue guidance
Flu season and China Covid outbreak boosts demand.